Cynata Therapeutics Limited Share Price
Stocks
CYP
AU000000CYP7
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
10:29:10 30/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.0120 AUD | 0.00% |
|
+9.09% | -96.52% |
| 22/10 | Cynata Therapeutics Limited Announces Resignation of Paul Wotton as Director, Effective November 25, 2026 | CI |
| 28/09 | Cynata Therapeutics Limited Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 29.21L 20.56L 18.42L 16.99L 15.37L 28.75L 20Cr 2.03Cr 80.86L 10Cr 77.16L 75.52L 32Cr | P/E 2025 |
-3.27x | P/E 2026 | -0.36x |
|---|---|---|---|---|---|
| Enterprise Value | 20.24L 14.24L 12.76L 11.77L 10.65L 19.92L 14Cr 1.4Cr 56.02L 7.1Cr 53.46L 52.32L 22Cr | EV / Sales 2025 |
15.3x | EV / Sales 2026 | 1.47x |
| Free-Float |
54.57% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| CYP | Delayed | |
OTC Markets
| CYYNF | Delayed | |
|
Deutsche Boerse AG
| 51S | Delayed | |
|
Börse Stuttgart
| 51S | Delayed |
Last Transcript: Cynata Therapeutics Limited
| 1 week | +9.09% | ||
| Current month | +9.10% | ||
| 1 month | +9.10% | ||
| 3 months | +0.01% | ||
| 6 months | -96.25% | ||
| Current year | -96.52% |
| 1 week | 0.01 |  | 0.01 |
| 1 month | 0.01 | | 0.02 |
| Current year | 0.01 | | 0.44 |
| 1 year | 0.01 | | 0.44 |
| 3 years | 0.01 | | 0.44 |
| 5 years | 0.01 | | 0.62 |
| 10 years | 0.01 | | 1.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mathias Kroll
PRN | Corporate Officer/Principal | - | 01/04/2024 |
Peter Webse
SEC | Corporate Secretary | 63 | 18/05/2012 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Wotton
CHM | Chairman | 65 | 28/02/2017 |
Kilian Kelly
BRD | Director/Board Member | - | 01/07/2023 |
Geoff Brooke
CHM | Chairman | 70 | 18/08/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/06/23 | Buy | Chief Executive Officer | 55,813 | 0.0312% | ||
| 01/06/23 | Buy | Chairman | 1,39,534 | 0.0780% | ||
| 01/06/23 | Buy | Director | 1,39,534 | 0.0780% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +9.09% | -95.38% | -91.11% | 20.56L | |
| +0.34% | +1.12% | +34.75% | +61.06% | 6.44TCr | |
| +0.98% | +2.68% | +12.25% | +82.98% | 5.62TCr | |
| +1.75% | +2.01% | +13.30% | +103.69% | 5.42TCr | |
| -1.43% | -1.17% | +26.27% | +52.86% | 4.53TCr | |
| -0.48% | -2.80% | +18.01% | +117.99% | 4.22TCr | |
| +0.82% | +1.37% | +227.94% | +922.41% | 4.08TCr | |
| -2.07% | +42.73% | +103.77% | +88.74% | 3.38TCr | |
| -0.26% | -2.57% | +12.55% | +45.18% | 3.22TCr | |
| -1.38% | -2.93% | +21.54% | -11.96% | 2.36TCr | |
| Average | -0.17% | +4.96% | +37.50% | +137.18% | 3.93TCr | |
| Weighted average by Cap. | +0.03% | +3.60% | +49.18% | +161.40% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 18.85L 13.27L 11.88L 10.96L 10L 18.55L 13Cr 1.31Cr 52.18L 6.61Cr 49.79L 48.73L 21Cr | 17.12L 12.05L 10.79L 10L 9L 16.84L 11Cr 1.19Cr 47.38L 6Cr 45.21L 44.25L 19Cr |
| Net income | -93.91L -66.09L -59.2L -54.61L -49.42L -92.41L -63Cr -6.52Cr -2.6Cr -33Cr -2.48Cr -2.43Cr -104.32Cr | -92.49L -65.09L -58.3L -53.79L -48.67L -91.02L -62Cr -6.42Cr -2.56Cr -32Cr -2.44Cr -2.39Cr -102.75Cr |
| Net Debt | -50.5L -35.54L -31.83L -29.37L -26.58L -49.69L -34Cr -3.5Cr -1.4Cr -18Cr -1.33Cr -1.31Cr -56Cr | -9L -6L -6L -5L -5L -9L -6.01Cr -62.27L -24.84L -3.15Cr -23.7L -23.2L -9.97Cr |
Employees
2
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | A$0.0120 | 0.00% | 1,11,168 |
| 29/26/29 | A$0.0120 | 0.00% | 83,000 |
| 28/26/28 | A$0.0120 | +9.09% | 1,89,047 |
| 27/26/27 | A$0.0110 | 0.00% | 3,00,923 |
| 26/26/26 | A$0.0110 | 0.00% | 20,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CYP Stock
Select your edition
All financial news and data tailored to specific country editions
